Rejected at 3:16 a.m. Nov, 01, 2023 ] by dollajas
Author: kfw001
Related Note: 1514576041266
Rationale for change

Easy to remember MACrolide for MAC
Source: Other - Me

Rejection reason

not necessary, add to your own personal fields

Text Text
Extra
- cART = Combined antiretroviral therapy

- Per AMBOSS and UTD, although a macrolide is no longer recommended for MAC prophylaxis in patients taking cART, it is still recommended for patients with a CD4+ count < 50/mm3 who are not immediately started on effective cART (e.g., because they refuse ART)

CD4 count (cells/μL)InfectionIndicationProphylaxis
< 250CoccidioidomycosisReside in endemic area AND If (+) IgG or (+) IgMFluconazole
< 200Pneumocystis pneumoniaEveryoneTMP-SMX
< 100Toxoplasma gondiiPositive serologyTMP-SMX
< 50Mycobacterium avium complexNo active infection + not on fully suppressive ARTAzithromycin OR clarithromycin
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
 


Watch Leprosy Drugs



Watch Macrolides [Old Version]
Sketchy 2
Sketchy Extra


Watch Mycobacterium avium intracellulare, Mycobacterium scrofulaceum, Mycobacterium marinum



Watch Macrolides
Picmonic
Empty field
Pixorize
Empty field
Physeo


Bootcamp
Watch associated Bootcamp video - Cytomegalovirus, Disseminated Mycobacterial Non-Tuberculous Disease

Watch associated Bootcamp video - Antibiotics: Macrolides

Watch associated Bootcamp video - Antibiotics: Rifamycins

Watch associated Bootcamp video - Antibiotics: Pyrazinamide, Ethambutol, Dapsone, and Clofazimine
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Microbiology::35_Opportunistic_Infections::07_Cytomegalovirus,_Disseminated_Mycobacterial_Non-Tuberculous_Disease #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::14_Macrolides #AK_Step2_v12::$AnKingUpdates::$Errata::v10-minor_text_changes #AK_Step1_v12::#B&B::13_Infectious_Disease::02_Bacteria::08_Mycobacteria #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::22_Dapsone,_Rifamycins,_Clofazimine_(Leprosy_Drugs) #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::02_Inhibitors_of_Bacterial_Protein_Synthesis::02_Macrolides #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::08_Mycobacteria::Mycobacterium_Avium_Complex #AK_Step2_v12::$AnKingUpdates::$Errata::v11 #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::16_Macrolides #AK_Step2_v12::#Resources_by_rotation::IM::amboss_medicalark #AK_Step2_v12::Original_decks::Dorian::im::ome::infection::hiv #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::27_Antimycobacterial_therapy #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::03_Antimycobacterials::02_Leprosy_Drugs::zanki_extra #AK_Step2_v12::#UWorld::Step::3252 #AK_Step2_v12::#AMBOSS::IF0Yj3 #AK_Step2_v12::#UWorld::COMLEX::100060 #AK_Step2_v12::#Resources_by_rotation::IM::ome::infection::hiv #AK_Step2_v12::!Shelf::IM #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step2_v12::#B&B::08_Infectious_Disease::03_HIV::01_HIV_Infection::Extra #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::08_Mycobacteria::Mycobacterium_Avium_Complex::Prophylaxis #AK_Step1_v12::#SketchyMicro::01_Bacteria::08_Mycobacteria::03_Mycobacterium_avium_intracellulare,_Mycobacterium_scrofulaceum,_Mycobacterium_marinum #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Rifamycins #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_2::Antibacterials::Antimycobacterials #AK_Step1_v12::$AnKingUpdates::$Errata::v11 #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::23_Rifamycins #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step2_v12::Original_decks::MedicalArk::im::amboss !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::Retired_Lessons::04_HIV_&_AIDS::03_AIDS_SOAP_[OLD_VERSION] !AK_UpdateTags::Table::HIV_Opportunistic_Prophylaxis